Literature DB >> 7504407

Chagas' disease cardioneuropathy: association of anti-Trypanosoma cruzi and anti-sciatic nerve antibodies.

S Gea1, P Ordonez, F Cerban, D Iosa, C Chizzolini, E Vottero-Cima.   

Abstract

The aim of this work was to study whether Trypanosoma cruzi infection could elicit humoral immune response to the well-defined parasite antigen acidic fraction separated from T. cruzi cytosol by isoelectric focusing and designated fraction IV (FIV) and whether this response could account for some of the autoreactive immune response against peripheral nerve components. Chagasic patients with positive serology for Chagas' disease were classified as group I (n = 12) with normal electrocardiograms (ECG) and no signs of disease, group II (n = 12) with ECG abnormalities but without cardiomegaly, and group III (n = 12) with cardiomegaly and congestive heart failure. Sera from patients in group II showed the highest frequency of positive reactivity against FIV. Ninety-two percent had titers higher than 1/400 while the percentage for groups I and III was 50%. The autoreactive response against human sciatic nerve saline extract (SNS) was studied. The binding of IgG to SNS was positive in groups I (58%), II (66%), and III (75%) patients. The treatment of SNS with periodate diminished the ability of antigens to fix IgG from these chagasic patients. Absorption studies were performed to investigate whether FIV and SNS could have cross-reactive epitopes. Preabsorption of positive sera with FIV inhibited 48-69% of samples' reactivity against antigen. In contrast, preabsorption of positive sera with SNS inhibited only 12-23% of samples' reactivity against antigen. Overall, these results suggest that FIV-T. cruzi and sciatic nerve components possess some epitopes, possibly of a carbohydrate nature, in common. Thus, infection in Chagas' disease could overcome the tolerance to self components and could lead to autoimmunity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7504407     DOI: 10.4269/ajtmh.1993.49.581

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  8 in total

Review 1.  Chagas' disease and the autoimmunity hypothesis.

Authors:  F Kierszenbaum
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

2.  Signature biochemical properties of broadly cross-reactive HIV-1 neutralizing antibodies in human plasma.

Authors:  Mohammad M Sajadi; George K Lewis; Michael S Seaman; Yongjun Guan; Robert R Redfield; Anthony L DeVico
Journal:  J Virol       Date:  2012-02-29       Impact factor: 5.103

3.  Anti-galectin-1 autoantibodies in human Trypanosoma cruzi infection: differential expression of this beta-galactoside-binding protein in cardiac Chagas' disease.

Authors:  L Giordanengo; S Gea; G Barbieri; G A Rabinovich
Journal:  Clin Exp Immunol       Date:  2001-05       Impact factor: 4.330

Review 4.  The role of infections in autoimmune disease.

Authors:  A M Ercolini; S D Miller
Journal:  Clin Exp Immunol       Date:  2009-01       Impact factor: 4.330

Review 5.  Autoimmunity in Chronic Chagas Disease: A Road of Multiple Pathways to Cardiomyopathy?

Authors:  Elidiana De Bona; Kárita Cláudia Freitas Lidani; Lorena Bavia; Zahra Omidian; Luiza Helena Gremski; Thaisa Lucas Sandri; Iara J de Messias Reason
Journal:  Front Immunol       Date:  2018-08-06       Impact factor: 7.561

6.  Recombinant antibody against Trypanosoma cruzi from patients with chronic Chagas heart disease recognizes mammalian nervous system.

Authors:  Leticia L Niborski; Mariana Potenza; Renato G S Chirivi; Leandro Simonetti; Micaela S Ossowski; Vanina Grippo; Maria May; Daniela I Staquicini; Adriana Parodi-Talice; Carlos Robello; Marcelo A Comini; Guillermo D Alonso; Jos M H Raats; Karina A Gómez
Journal:  EBioMedicine       Date:  2021-01-08       Impact factor: 8.143

7.  Evolution of anti-Trypanosoma cruzi antibody production in patients with chronic Chagas disease: Correlation between antibody titers and development of cardiac disease severity.

Authors:  Ingebourg Georg; Alejandro Marcel Hasslocher-Moreno; Sergio Salles Xavier; Marcelo Teixeira de Holanda; Eric Henrique Roma; Maria da Gloria Bonecini-Almeida
Journal:  PLoS Negl Trop Dis       Date:  2017-07-19

8.  Myelin- and microbe-specific antibodies in Guillain-Barré syndrome.

Authors:  J Terryberry; M Sutjita; Y Shoenfeld; B Gilburd; D Tanne; M Lorber; I Alosachie; N Barka; H C Lin; P Youinou
Journal:  J Clin Lab Anal       Date:  1995       Impact factor: 2.352

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.